Lorenzo Maso

About Lorenzo Maso

Lorenzo Maso, With an exceptional h-index of 11 and a recent h-index of 10 (since 2020), a distinguished researcher at Università degli Studi di Padova,

His recent articles reflect a diverse array of research interests and contributions to the field:

Snapshots of Pseudomonas aeruginosa SOS response activation complex reveal structural prerequisites for LexA engagement and cleavage

Exploring switch II pocket conformation of KRAS (G12D) with mutant-selective monobody inhibitors

Abstract B020: Creating actionable neoantigens by design with KRAS (G12C) covalent inhibitors

Abstract B013: Exploring the switch II pocket of KRAS (G12D) with mutant-selective monobody inhibitors

Creating MHC-restricted neoantigens with covalent inhibitors that can be targeted by immune therapy

Nanobodies targeting LexA autocleavage disclose a novel suppression strategy of SOS-response pathway

The ataxia-linked E1081Q mutation affects the sub-plasma membrane Ca2+-microdomains by tuning PMCA3 activity

Development, characterization and engineering of anti-LexA nanobodies as suppressors of the bacterial SOS response

Lorenzo Maso Information

University

Position

___

Citations(all)

306

Citations(since 2020)

287

Cited By

114

hIndex(all)

11

hIndex(since 2020)

10

i10Index(all)

11

i10Index(since 2020)

10

Email

University Profile Page

Google Scholar

Top articles of Lorenzo Maso

Snapshots of Pseudomonas aeruginosa SOS response activation complex reveal structural prerequisites for LexA engagement and cleavage

bioRxiv

2024

Exploring switch II pocket conformation of KRAS (G12D) with mutant-selective monobody inhibitors

Proceedings of the National Academy of Sciences

2023/7/11

Abstract B020: Creating actionable neoantigens by design with KRAS (G12C) covalent inhibitors

Molecular Cancer Research

2023/5/1

Abstract B013: Exploring the switch II pocket of KRAS (G12D) with mutant-selective monobody inhibitors

Molecular Cancer Research

2023/5/1

Creating MHC-restricted neoantigens with covalent inhibitors that can be targeted by immune therapy

Cancer discovery

2023/1/9

The ataxia-linked E1081Q mutation affects the sub-plasma membrane Ca2+-microdomains by tuning PMCA3 activity

Cell Death & Disease

2022/10/7

Development, characterization and engineering of anti-LexA nanobodies as suppressors of the bacterial SOS response

FEBS Open Bio

2022/7

Unveiling the binding mode of perfluorooctanoic acid to human serum albumin

Protein Science

2021/4

VIrtual screening identifies cross-class inhibitors of clinically relevant serine-and metallo-beta lactamases

2021

Targeting the class a carbapenemase GES-5 via virtual screening

Biomolecules

2020/2

ER-mitochondria calcium transfer, organelle contacts and neurodegenerative diseases

2020

Virtual screening identifies broad-spectrum β-lactamase inhibitors with activity on clinically relevant serine- and metallo-carbapenemases

Scientific Reports

2020/7/29

4-Amino-1,2,4-triazole-3-thione as a Promising Scaffold for the Inhibition of Serine and Metallo-β-Lactamases

Pharmaceuticals

2020/3/24

See List of Professors in Lorenzo Maso University(Università degli Studi di Padova)